| DAH30 | |||
---|---|---|---|---|
Female | Male | |||
Median | IQR | Median | IQR | |
Patient factors | ||||
 CCI ≥ 2 | 19 | 10–23 | 22 | 16–24 |
 COPD | 19 | 11–23 | 21 | 14–24 |
 Diabetes | 21 | 15–24 | 23 | 19–25 |
 Peripheral vascular disease | 20 | 12–23 | 22 | 16–24 |
 Atrial fibrillation | 18 | 9–22 | 20 | 13–23 |
 Stroke/TIA | 18 | 7–23 | 21 | 13–24 |
 Chronic liver disease | 13 | 0–21 | 18 | 6–23 |
Chronic kidney disease | ||||
 Stage 1 | 23 | 21–25 | 24 | 22–25 |
 Stage 2 | 22 | 18–24 | 23 | 21–25 |
 Stage 3 | 19 | 11–23 | 21 | 15–24 |
 Stage 4 | 13 | 0–20 | 16 | 1–22 |
 Stage 5 | 13 | 0–20 | 17 | 3–22 |
Income Quintile | ||||
 Q1 | 21 | 14–24 | 23 | 19–25 |
 Q2 | 22 | 16–24 | 23 | 20–25 |
 Q3 | 22 | 16–24 | 24 | 20–25 |
 Q4 | 22 | 16–24 | 24 | 20–25 |
 Q5 | 22 | 17–24 | 24 | 21–25 |
Smoking Status | ||||
 Current | 22 | 16–24 | 24 | 20–25 |
 Ex-smoker | 22 | 16–24 | 23 | 20–25 |
 Never smoked | 22 | 16–24 | 23 | 20–25 |
Left ventricular ejection fraction | ||||
 < 20% | 19 | 4–23 | 20 | 10–24 |
 20%—34% | 19 | 9–23 | 22 | 16–24 |
 35%—49% | 21 | 14–24 | 23 | 19–25 |
  ≥ 50% | 22 | 17–24 | 24 | 21–25 |
 Preoperative ICU | 22 | 16–24 | 23 | 20–25 |
BMI | ||||
  ≤ 25 | 22 | 16–24 | 23 | 19–25 |
 26–30 | 22 | 17–24 | 24 | 21–25 |
  ≥ 31 | 22 | 16–24 | 23 | 20–25 |
Surgeries | ||||
 Isolated CABG | 23 | 18–24 | 24 | 21–25 |
Single non-CABG | ||||
 Aortic valve | 22 | 18–24 | 23 | 19–25 |
 Mitral valve | 22 | 17–24 | 23 | 20–25 |
 Pulmonic/tricuspid | 20 | 4–23 | 21 | 13–24 |
 Aneurysectomy/aortic | 16 | 4–21 | 21 | 14–24 |
Combined Surgeries | ||||
 CABG/valve ± other | 19 | 10–23 | 21 | 15–24 |
 Double valve | 19 | 11–22 | 20 | 13–23 |
  ≥ 3 proceduresa | 16 | 2–21 | 19 | 9–22 |
 Otherb | 21 | 15–24 | 23 | 17–24 |